Inactive Instrument

BioTelemetry, Inc.

Equities

BEAT

US0906721065

Healthcare Facilities & Services

BioTelemetry, Inc. Withdraws Financial Guidance for the Full Year of 2020

May 06, 2020 at 10:05 pm

BioTelemetry is withdrawing its previous financial guidance issued on February 26, 2020 for the full year of 2020. Given the uncertain scope and duration of the pandemic, BioTelemetry is unable to estimate the impact of the COVID-19 outbreak on its operations and financial results.

Latest news about BioTelemetry, Inc.

Ayala Pharmaceuticals, Inc. announced that it has received $2 million in funding from Israel Biotech Fund, Arkin Bio Venture Partners Ltd., BioTelemetry, Inc.	02-29	CI
Ayala Pharmaceuticals, Inc. entered into a definitive merger agreement to acquire BioSight Ltd from Israel Biotech Fund, BioTelemetry, Inc., Arkin Bio Venture Partners Ltd., Primera Capital, SBI JI Innovation Advisory Ltd., Migdal Insurance Company Ltd., The Phoenix Insurance Company Ltd. and others.	26/07/23	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P Health Care Services Select Industry Index	10/02/21	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P 600	10/02/21	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P Composite 1500	10/02/21	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P 600 Health Care Services (Sub Ind)	10/02/21	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P 1000	10/02/21	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P TMI Index	10/02/21	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P Global BMI Index	10/02/21	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P 600 Health Care	10/02/21	CI
BioTelemetry, Inc. Announces Board Changes	09/02/21	CI
BioTelemetry, Inc. Terminates Amended and Restated Credit Agreement	09/02/21	CI
Koninklijke Philips N : Royal Philips Completes Tender Offer to Acquire BioTelemetry at $72 per Share	09/02/21	MT
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from NASDAQ Composite Index	09/02/21	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from Russell 2000 Defensive Index	09/02/21	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from Russell 2000 Growth-Defensive Index	09/02/21	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from Russell 2500 Defensive Index	09/02/21	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from Russell 2500 Growth-Defensive Index	09/02/21	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell 2000 Dynamic Index	09/02/21	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell 2000 Index	09/02/21	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell 3000 Index	09/02/21	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell 2500 Index	09/02/21	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell 2000 Growth Index	09/02/21	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell Small Cap Completeness Index	09/02/21	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell Small Cap Comp Growth Index	09/02/21	CI

Chart BioTelemetry, Inc.

Duration

Period

More charts

Company Profile

BioTelemetry, Inc. is a remote medical technology company focused on delivery of health information. The Company is principally engaged in providing remote cardiac monitoring, centralized core laboratory services for clinical trials, remote blood glucose monitoring, and original equipment manufacturing that serves both healthcare and clinical research customers. The Company operates in two segments: Healthcare and Research. The Healthcare segment is focused on remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders and to monitor the functionality of implantable cardiac devices. It offers cardiologists, electrophysiologists and primary care physicians a full spectrum of solutions, which provides them with a single source of cardiac monitoring services. The Research segment is engaged in centralized core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials.

Sector

Healthcare Facilities & Services

More about the company

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
HCA HEALTHCARE, INC.	+17.74%	82.59B
CVS HEALTH CORPORATION	-29.66%	69.86B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	0.00%	26.5B
FRESENIUS SE & CO. KGAA	+3.06%	17.29B
LABCORP HOLDINGS INC.	-12.16%	16.61B
QUEST DIAGNOSTICS INCORPORATED	+2.47%	15.56B
NATERA, INC.	+74.82%	13.2B
REDE D'OR SÃO LUIZ S.A.	+0.76%	12.75B
TENET HEALTHCARE CORPORATION	+73.52%	12.6B

Other Healthcare Facilities & Services